O([C@@H] 1O[C@@H] ([C@@H] ([C@@H] ([C@H] 1O) O[C@] 2(O[C@] ([C@@H] ([C@H] (C2) O) NC(C) =O) ([C@@H] ([C@@H] (CO) O) O) [H] ) C(O) =O) O) CO) C[C@@H] ([C@@H] (/C=C/CCCCCCCCCCCCC) O) NC(=O) * |
|
Mus musculus
(NCBI:txid10090)
|
Source: BioModels - MODEL1507180067
See:
PubMed
|
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
|
|
View more via ChEBI Ontology
Outgoing
|
N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosylceramide
(CHEBI:27499)
has role
mouse metabolite
(CHEBI:75771)
N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosylceramide
(CHEBI:27499)
is a
sialomonoglycosylceramide
(CHEBI:36546)
N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosylceramide
(CHEBI:27499)
is conjugate acid of
N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosylceramide(1−)
(CHEBI:78482)
|
|
Incoming
|
N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosylceramide(1−)
(CHEBI:78482)
is conjugate base of
N-acetyl-α-neuraminosyl-(2→3)-β-D-galactosylceramide
(CHEBI:27499)
|
(2S,3R,4E)- 2- alkanamido- 3- hydroxyoctadec- 4- en- 1- yl 5- acetamido- 3,5- dideoxy- D- glycero- α- D- galacto- non- 2- ulopyranonosyl- (2→3)- β- D- galactopyranoside
|
(2S,3R,4E)- 2- alkanamido- 3- hydroxyoctadec- 4- en- 1- yl 3- O- (5- acetamido- 3,5- dideoxy- D- glycero- α- D- galacto- non- 2- ulopyranonosyl)- β- D- galactopyranoside
|
IUPAC
|
(Gal)1 (Neu5Ac)1 (Cer)1
|
KEGG GLYCAN
|
α-Neu5Ac-(2→3)-β-D-Gal-(1↔1')-Cer
|
ChEBI
|
α-Neup5Ac-(2→3)-β-D-Galp-(1↔1')-Cer
|
ChEBI
|
ganglioside GM4
|
ChEBI
|
N-Acetylneuraminyl-galactosylceramide
|
KEGG COMPOUND
|
NeuAcα2-3Galβ-Cer
|
LIPID MAPS
|
NeuAcα2→3Gal-Cer
|
ChEBI
|
15546874
|
PubMed citation
|
Europe PMC
|
156
|
PubMed citation
|
Europe PMC
|
1567198
|
PubMed citation
|
Europe PMC
|
16341241
|
PubMed citation
|
Europe PMC
|
2448252
|
PubMed citation
|
Europe PMC
|
|